Table 1. Demographic and clinical characteristics of cirrhotic patients with hepatocellular carcinoma.
| Frequency | Percentage | p value | |
|---|---|---|---|
| Telomere length classification* | 0.01 | ||
| <p25% | 29 | 24 | |
| p25 –p50 | 31 | 26 | |
| p50 –p75 | 30 | 25 | |
| >p75% | 30 | 25 | |
| Age (years) | 0.1 | ||
| Female (39–79) | |||
| Male (28–85) | |||
| Median (<p50%: 59; >p50%: 58.5) | |||
| Gender | <0.01 | ||
| Female | 18 | 15 | |
| Male | 102 | 85 | |
| Primary disease | |||
| NASH | 1 | 1 | |
| Cirrhosis | 116 | 97 | |
| Hepatitis | 3 | 2 | |
| Etiology | >0.05 | ||
| Hepatitis B virus | 13 | 11 | |
| Hepatitis C virus | 35 | 29 | |
| Alcoholism | 21 | 17.5 | |
| Virus (B or C) + Alcoholism | 39 | 32.5 | |
| Cryptogenic | 7 | 6 | |
| NASH | 4 | 3 | |
| HH | 1 | 1 | |
| CHILD | 0.6 | ||
| A | 60 | 50 | |
| B | 38 | 32 | |
| C | 18 | 15 | |
| ND | 4 | 3 | |
| MELD | 0.4 | ||
| <10 | 28 | 23 | |
| 10–19 | 80 | 67 | |
| 20–29 | 6 | 5 | |
| ND | 6 | 5 | |
| Tumor presentation | |||
| Diffuse infiltrative | 16 | 13 | |
| Multinodular | 28 | 23 | |
| Uninodular | 75 | 63 | |
| ND | 1 | 1 | |
| Milan criteria | |||
| No | 54 | 45 | |
| Yes | 66 | 55 | |
| Metastasis | |||
| Adrenal | 1 | 1 | |
| Lung | 2 | 2 | |
| Bone | 5 | 4 | |
| No research | 8 | 7 | |
| No | 104 | 86 | |
| BCLC | 0.8 | ||
| A1 | 7 | 6 | |
| A2 | 12 | 10 | |
| A3 | 14 | 12 | |
| A4 | 19 | 16 | |
| B | 28 | 23 | |
| C | 22 | 18 | |
| D | 18 | 15 | |
* T/S ratio; p = percentile
NASH: non-alcoholic steatohepatites; HH: Hereditary hemochromatosis; CHILD: Child-Pugh score; MELD: Model for End-Stage Liver Disease; BCLC: Barcelona-Clinic Liver Cancer; ND: follow up lost.